期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

Y-盒结合蛋白1短发夹环RNA真核表达载体的构建 被引量：2

Generation of eukaryotic expression vector of shRNA specific for Y-box binding protein-1
暂未订购
导出
摘要 目的:构建Y-盒结合蛋白1(Y-box binding protein-1,YB-1)特异性短发夹环RNA(shRNA)真核表达载体。方法:采用人U6SnRNA启动子,分别把被9 bp序列间隔的19 bp长短的YB-1靶序列的反向重复序列,置于pGensil-1质粒载体中,构建成YB-1短发夹环RNA,产生重组质粒pGensil-1/U6/YBX11,pGensil-1/U6/YBX12及pGensil-1/U6/YBX13。分别用PstⅠ和SalⅠ酶切鉴定;并将经酶切鉴定正确后的重组质粒作测序分析。结果:YB-1的特异性shR-NA片段被成功克隆进pGensil-1质粒中,SalⅠ酶切鉴定可切出400 bp大小的片段,DNA测序分析显示,重组质粒shRNA编码序列与设计片断的序列完全一致。结论:成功构建了针对YB-1的特异性shRNA真核表达载体pGensil-1/U6/YBX11,pGensil-1/U6/YBX12及pGensil-1/U6/YBX13,为进一步研究其基因功能打下了基础。 Objective： To generate eukaryotic expression vector of short hairpin RNA （shRNA） specific for Y-box binding protein-1 （YB-1）. Methods： A plasmid pGensil-1 containing human U6SnRNA promoter was legated to a 19 bp reverse repeated motif of YB-1 target sequence with 9 bp spacer. Enzyme digestion and DNA sequencing were used to examine whether the recombinant plasmid pGensil-1/U6/YBX11, pGen- sil-1/U6/YBX12 or pGensil-1/U6/YBX13 was correct. Results： The YB-1 shRNA expression frame was successfully inserted into eukaryotic expression vector pGensil-1 with U6SnRNA promoter and termination signal of RNA polymerase Ⅲ. Enzyme digestion by Pst I and Sal I got a 400bp DNA fragment. The sequences of shRNA recombinant plasmid were the same as that of designed fragments. Conclusion： Eukaryotic expression vectors of shRNA specific for YB-1 were generated successfully. Our study may start a new approach to research the gene function of YB-1 and the method of gene therapy.
作者 周磊磊 许文林 秦茹娟 唐华容 沈慧玲
机构地区 江苏大学附属人民医院中心实验室 江苏大学附属人民医院肿瘤科
出处 《江苏大学学报（医学版）》 CAS 2007年第1期35-37,65,共4页 Journal of Jiangsu University：Medicine Edition
基金 江苏省卫生重大课题基金资助项目(K2005017)
关键词 RNA干扰 YB-1 短发夹环RNA U6SnRNA启动子 RNA interference YB-1 short hairpin RNA U6SnRNA promoter
分类号 R392.1 [医药卫生—免疫学]
  • 相关文献

参考文献9

  • 1Yu JY, DeBuiter SL, Turner DL. BNA interference by expression of short-interfering BNAs and hairpin BNAs inmammalian cells[J]. Proc Nail Acad Sci USA, 2002,99(9) : 6047 -6051.
  • 2Fromm MF. The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans [ J ].Adv Drug Deliv Rev, 2002, 18(10) :1295 -1310.
  • 3Huang J, Tan PH, Li KB, et al. Y-box binding protein,YB-1, as a marker of tumor aggressiveness and response to adjuvant chemotherapy in breast cancer[J]. Int J Oncol, 2005, 26(3):607-613.
  • 4Didier DK, Schiffenhauer J, Woulfe SL, et al. Characterization of the eDNA encoding a protein binding to the major histo-eompatability complex class Ⅱ Y box [ J ].Proc Nail Acad Sci USA, 1988, 85:7322-7326.
  • 5Fujita T, Ito K, Izumi H, et al. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel [ J ]. Clinical Cancer Res, 2005, 11 (24) : 8837 - 8844.
  • 6Ute R, Bjom F, Thomas R, et al. Splicing factor SRp30c interaction with Y-box protein-1 coders nuclear YB-1 shuttling and alternative splice site selection [ J ]. J Biol Chem, 2003, 278 (20) : 18241 - 18248.
  • 7Annette L, Stephanie M, Traey H, et al. The Y-boxbinding protein, YBI, is a potential negative regulator of the p53 tumor suppressor [ J ]. J Biol Chem, 2003,278 ( 37 ) :35516 - 35523.
  • 8Bader AG, Vot PK. Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation[J]. Mol Cell Biol, 2005, 25(6) :2095 -2106.
  • 9Miyagishi M, Taira K. U6 promoter-driven siRNAs with four uridine 3 overhangs efficiently suppress targeted gene expression in mammalian cells[J]. Nat Biotechnol, 2002, 20(5):497-500.

同被引文献22

  • 1Rafletseder U, Frye B, Rauen T, et al. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. J Biol Chem, 2003 ; 278 ( 20 ) : 18241 - 18248.
  • 2Bader AG, Vot PK. Inhibition of protein synthesis by Y box- binding protein 1 blocks oncogenic cell transformation. Mol Cell Biol, 2005; 25(6): 2095-2106.
  • 3Skabkin MA, Kiselyova OI, Chemov KG, et al. Structural organization of mRNA complexes with major core mRNP protein YB-1. Nucleic Acids Res, 2004 ;32(18) : 5621 -5635.
  • 4Terry G, Ho L, Londesborough P, et al. The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions. Br J Cancer, 2007 ;96( 1 ) : 110 - 117.
  • 5Yoshimatsu T, Uramoto H, Oyama T, et al. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer. Anticancer Res, 2005, 25(5): 3437-3443.
  • 6Jurchott K, Bergmarm S, Stein U, et al. YB-1 as a cell cycleregulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem, 2003; 278(30) : 27988 -27996.
  • 7Hu Q, Bhattacharya C, Maity SN. CCAAT binding factor (CBF) binding mediates cell cycle activation of topoisomerase Ha. J Biol Chem, 2002; 277(40) : 37191 -37200.
  • 8Hu Z, Jin S, Scotto KW, et al. Transcriptional activation of the MDR1 gene by UV irradiation. J Biol Chem, 2000; 275(4) : 2979 - 2985.
  • 9Shibahara K, Sugio K, Osaki T, et al. Nuclear expression of the Y-box binding protein, YB-1, as a novel marker of disease progression in non-smaU cell lung cancer. Clin Cancer Res, 2001 ; 7(10) : 3151 -3155.
  • 10Huang X, Ushijima K, Komai K, et al. Co-expression of Y box- binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Gynecol Oncol, 2004 ;93 (2) : 287 -291.

引证文献2

江苏大学学报（医学版）
2007年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部